Iin conjunction w/ a mildly hypocaloric diet for obese (BMI ≥30 kg/m
2) & overwt (BMI ≥28 kg/m
2) patients including patients w/ risk factors associated w/ obesity. In type 2 diabetic patients, provides additional glycemic control when used in combination w/ antidiabetic agents eg, metformin, sulfonylurea &/or insulin.